Adenocarcinoma is one type of cancer, which starts the glandular cell (producing mucus or other fluids) in organs, including the pancreas, stomach, lungs, colon, and uterus. These tumors might remain silent and in case of not being treated, may either spread or (metastasize) to far areas of the body.
Symptoms vary by the organ affected but may include:
A combination of environmental and genetic factors can increase the risk:
At GastroDoxs in Katy, we have a mission of ensuring that we take you through all your adenocarcinoma process with professionalism and love. Now schedule your appointment and be able to get personalized treatment planning, clear communication and the support you want- all to yourself just around the corner.
We've successfully treated more than 1.5K patients, helping individuals improve their digestive health and overall well-being through expert, personalized care.
With over 20 years of experience, GastroDoxs has been a trusted provider of gastroenterology care, focusing on delivering the best outcomes for patients
The code is determined by the extent of cancer spread. Secondary malignant neoplasms are coded in the C78.x range (e.g., C78.0 for lung metastasis, C78.5 for liver metastasis).
Pancreatic adenocarcinoma is coded as C25.x in ICD-10. The fourth digit (C25.0–C25.9) specifies the exact location within the pancreas.
Stage 3 pancreatic cancer is locally advanced, possibly involving nearby blood vessels or lymph nodes, but without distant metastasis. Stage 4 indicates that the cancer has spread to distant organs such as the liver, lungs, or peritoneum.
Lung adenocarcinoma is coded as C34.x. The fifth character specifies the bronchus or lobe (e.g., C34.1 is upper lobe). Staging is from I to IV.
Endometrial (uterine lining) adenocarcinoma is coded as C54.x, with subcategories C54.0–C54.9 specifying particular parts of the uterus.
Gastric adenocarcinoma is coded as C16.x. The fourth and fifth digits identify the tumor’s specific location (e.g., C16.0 for cardia, C16.2 for the body of the stomach).
GastroDoxs in Katy has a multidisciplinary team including board-certified gastroenterologists, oncologists, surgeons, radiologists, and specialized nursing staff experienced in adenocarcinoma care.
Screening should be considered in individuals with persistent symptoms (unexplained weight loss, pain, bleeding), strong family history of cancer, or abnormal imaging/lab results to facilitate early diagnosis and treatment.
Stage 4 non-small cell lung cancer treatments include targeted therapy based on genetic markers, immunotherapy, combination organ treatment, and palliative care to improve symptoms and quality of life.
Yes, second opinions are available. Patients should bring imaging, pathology reports, and treatment history documents for review, and the team will guide subsequent management steps.